Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Genotropin placebo-controlled trial in growth hormone deficiency after traumatic brain injury
NL-OMON31323Phase 4Active, not recruiting
- Sponsor
- Pfizer
- Start
- Sep 2008
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial of somatropin in growth hormone deficiency (GHD), sponsored by Pfizer. Started Sep 2008; status: active, not recruiting.
02
Drugs
somatropin
03
Conditions
growth hormone deficiency (GHD)
Beyond the preview
Go deeper on NL-OMON31323.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON31323.